Thyrocare Technologies informs about analyst meet

13 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chainnan, Managing Director & CEO, Anand Velumani, Director of the company’s wholly owned subsidiary, Nueclear Healthcare, Dr. Caesar Sengupta, Vice-President-Operations and Sachin Salvi, General Manager-Finance, at the office by 11.00 AM on Monday, December 17, 2018. There could be last minute change in the timings or in the names of the officers the analysts would be meeting. No un-published Price-Sensitive Information will be shared during the above meeting.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

957.45 -12.90 (-1.33%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6932.35
Max Healthcare Inst 999.80
Narayana Hrudayalay 1271.85
Aster DM Healthcare 432.35
Global Health 1114.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.